Neuraxis, Inc. (NRXS) support and resistance · rev $3.6M
Neuraxis, Inc. (NRXS) is a biotechnology company listed on AMEX.
This page maps Neuraxis, Inc. (NRXS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported NRXS revenue for 2025-12-31 was $3.6M. Net income was -$7.8M. Revenue was up 32.9% from 2024-12-31 to 2025-12-31. NRXS currently screens at market cap $83.1M.
NRXS currently screens at market cap $83.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new NRXS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the NRXS quote page for the session range and the stock page for the full model.
Not investment advice.